CU Gynecologic Oncology Research

🎉Congratulations to Katharine Linder, MD, Gyn Oncology fellow at CU Anschutz, on receiving the BRIDGES 2.0 Accelerator Research & Alice Chisolm Grant from the Foundation for Women's Cancer (FWC)! She’ll be recognized at the Society of Gynecologic Oncology 2026 Annual Meeting in April. bit.ly/4aP20pt

🎉 Congrats to Sam Lopez Alvarez for being selected to have a poster at the Dept of Bioinformatics Conference this March! 🙌 And a huge shoutout to Stephanie Tanis for securing a short talk at the event! 👏 Check out more: medschool.cuanschutz.edu/dbmi/event
#Bioinformatics #CUAnschutz #GynOnc

Congrats to Dr. Bitler and Courtney Bailey, PhD candidate, on receiving a Grubstake Award from the CU Gates Institute! 🎉Their project, “Macrophage Backpacks for Delivering Olaparib to HGSC,” was awarded $300,000 over 2 years. bit.ly/4jXkQgW

@uccc-gorg.bsky.social @courtneybailey.bsky.social

The 2024 Ovarian Cancer Think Tank brought experts together to tackle questions in #GynOnc research. Explore key insights in the white paper - Ovarian Cancer Think Tank: The Use of Integrated AI and Computational Biology in Ovarian Cancer Diagnosis and Treatment #CUAnschutz
bit.ly/4pBuYx7

Welcome Lily Elizabeth Feldman, PhD! 🎉
Lily joins Dr. Bitler’s Gyn Oncology Research Group (GORG) at CU Anschutz as a new postdoctoral fellow. She completed her PhD in Pharmacology & Molecular Medicine and is also the Faculty Innovations Program Director at CU Innovations. 🧬
#CUAnschutz #GynOnc

🎗️Are you a gynecological cancer patient, survivor, caregiver, or provider? This conference is for you!

Hope & Healing: Gyn Cancer Survivorship & Beyond
🗓️ Thurs, Feb 5, 2026 
📍 CU Anschutz
🔗Registration link: loom.ly/sltGLsw

#CUAnschutz #Ovarian #Uterine #Endometrial #Cervical #Vulvar #Fallopian

Congrats to Scott Lin, MD, PhD Candidate, on being accepted into the PhRMA Foundation’s Predoctoral Drug Discovery Fellowship🎉50 researchers are selected for a share of $3.7M in funding to shape the future of drug discovery & translational medicine🌟 #GynOnc #CUAnschutz

View Article: bit.ly/4aaHUX0

From Lab to Clinic: CU Anschutz Launches Phase 1 Clinical Trial of Promising Combination Therapy for Resistant Ovarian Cancer From Lab to Clinic: CU Anschutz Launches Phase 1 Clinical Trial of Promising Combination Therapy for Resistant Ovarian Cancer

Drs. Brad Corr and Ben Bitler launched a Phase 1 clinical trial for a promising combination therapy to tackle resistant ovarian cancer. This groundbreaking research could offer new hope to patients #OvarianCancer #GynOnc #CUAnschutz 🧬🎉

Read the Press Release: bit.ly/3MjeXxY
@uccc-gorg.bsky.social

Exciting news🎉 Courtney Bailey, a CU Anschutz Gates Institute Grubstake Award finalist and PhD student, will present her research "Macrophage Backpacks for Delivering Olaparib to #HGSCs" on Nov 20, 4–6 PM at CU Innovations Executive Conference Room in the AHSB. #CUGynOnc @courtneybailey.bsky.social

Levi Watson, PhD, will be presenting on “Hematopoietic Stem Cell–Derived Adipocytes Influence the Ovarian Cancer Microenvironment” at the Ovarian Cancer Midwest Focus (OCMF) Conference in Minneapolis, MN, on November 10–11, 2025. For more information, visit: bit.ly/3JJy1oa

#CUAnschutz #GynOnc

CU Gynecologic Oncology was proud to join the HERA Ovarian Cancer Foundation’s Climb4Life & Gala! 🌄 Dr. Kian Behbakht spoke at the event & Taylor Benson, PhD, shared her HERA-funded research on WNT4 and metabolic biomarkers in #ovariancancer. 💙

For more information: bit.ly/3Lg6aMP
#CUAnschutz

Debunking 8 Myths About Cancer Clinical Trials Misunderstandings about cancer clinical trials – what they are and how they work – keep some people from accessing the life-saving treatments they offer.

✨Dr. Brad Corr, A CU Gynecologic Oncologist, is dispelling clinical trial myths! 🧪✅ Safe, innovative treatments empower patients to make informed care decisions.

📖 Read more: bit.ly/4hAKCGW 

#OvarianCancer #GynOnc #CUAnschutz

Join us for the Pharmacology Seminar Series as Dr. Elizabeth Woodruff discusses how chronic stress influences #HGSC progression and immune response through adrenergic signaling in the omentum. #OvarianCancer #GynOnc #CUAnschutz

Date 📅: Mon, 10/20/25, 12:00 PM MST
Location📍: RC1 North, Room 6107

Dr. Walsh with 9News

✨Dr. Christine Walsh, a leading Gynecologic Oncologist at the University of Colorado Anschutz, recently appeared on 9News to discuss genetics' role in gyn cancers as well as share insights on ovarian cancer.

👉 Watch the full interviews here: bit.ly/3KNj0lv 

#CancerGenetics #GynOc #CUAnschutz

‘I Love What I Do’: While She Helps Patients, a Nurse Grapples with Her Own Ovarian Cancer Toni Moses, RN, says she’s grateful to be enrolled in a clinical trial led by Bradley Corr, MD, of the CU Cancer Center.

Toni Moses, RN, is battling stage IV ovarian cancer while helping others—and participating in a trial led by Dr. Brad Corr & the CU Ovarian Cancer Innovations Group. 💙 Read her powerful story: news.cuanschutz.edu/cancer-cente...

#OvarianCancer #GynOnc #CUAnschutz

Thank you to all who attended the CU Ovarian Cancer Innovations Group (OCIG) Reception during the AACR Special Conference on #OvarianCancer! 💫 It was inspiring to connect with so many passionate researchers in Denver. Let’s keep the momentum going! #AACR #CUAnschutz
@uccc-gorg.bsky.social

Congrats to Dr. Liz Woodruff (Division of Repro Science) on receiving a $10K Cancer Innovation Pilot Grant from
@cucancercenter.bsky.social!
Her study explores how social stress/isolation impacts high-grade serous carcinoma (HGSC) progression & immune response🎉 @liz-woodruff.bsky.social #CUAnschutz

🎗️Attending the AACR Conference on Ovarian Cancer?

Visit Alan Elder’s poster "Discerning mechanisms of SEMA7A in therapy resistance & tumor progression in HGSC"

Also join the CU Ovarian Cancer Innovations Group (OCIG) Reception on Saturday, Sept 20th. Register here: bit.ly/47KvpA3

#AACRovca25

🎉Dr. Kian Behbakht from CU's Ovarian Cancer Innovations Group (OCIG) was featured on #BBC The Happy Pod🎙️He discussed the development of an ovarian cancer early detection test, which is being developed in partnership with AOA Dx. #OvarianCancer #CUAnschutz

👉 Listen here: www.bbc.com/audio/play/p...

Drs. Ben Bitler & Kian Behbakht, AOA Dx (a women-owned Denver biotech), and other GynOnc researchers co-published a study on a scalable, sensitive test using lipidomic and protein biomarkers with machine learning to improve early ovarian cancer detection. View Here: www.mdpi.com/2075-4418/15...

Help us welcome Drs. Katharine Linder and Daisy Cruz, our new CU GynOnc fellows joining the University of Colorado GynOnc Research Group (GORG) Lab this Fall 2025! Excited for the expertise and passion they'll bring to advancing women’s cancer research 🎉🎉 #GynOnc #CUAnschutz #OvarianCancer

🎉Dr. Lindsay Brubaker is tackling therapy resistance in #HGSC with cutting-edge research on antibody-drug conjugates (ADCs). Backed by a competitive DOD grant, her study explores epigenetic drivers to expand and improve treatment options. View Article bit.ly/4fxHr1E #OvarianCancer #CUAnschutz

Congrats to Drs. Ben Bitler and Jim Lambert on receiving an award from Golfers Against Cancer to advance ovarian cancer immunogenic cell death (ICD) research — pushing boundaries in cancer research #OvarianCancer #GynOnc #CUAnschutz 👏👏 @uccc-gorg.bsky.social

Congrats to Scott Lin, MD, PhD Candidate, on receiving the Cancer Biology T32 award from the National Cancer Institute! This prestigious award supports 5 predoctoral students each year with funding through the University of Colorado Cancer Center. 🎉🎉 #CUAnschutz #GynOnc @uccc-gorg.bsky.social

🔬Don’t miss Session 2 of our gynecologic cancer virtual series! Scott Lin, MD, PhD Candidate, will share insights on PARP inhibitors & ovarian cancer treatment. #OvarianCancer @uccc-gorg.bsky.social

📅 Aug 11 |🕛 12–1PM MST |💻 Virtual
Topic: PARP Inhibitors
Register today! bit.ly/40k8dUE

Congrats to Team Bitler—Drs. Bitler, Corr, Sikora, Clauset, and many others—2025 CU ASPIRE Awardees🎉Their SPORE effort to advance ovarian cancer care with novel therapies & population science. #OvarianCancer #CUAnschutz @uccc-gorg.bsky.social‬ @mjsikora.bsky.social View details here: Bit.ly/4mWBRsO

Congratulations to Courtney Bailey, PhD student in Biomedical Engineering at CU Boulder and part of the Gynecologic Oncology Research Group at CU Anschutz! She was awarded the Achievement Reward for College Scientist Scholarship. Well deserved! 👏 #CUAnschutz #CUBoulder #BiomedicalEngineering #GynOnc

Dr. Kian Behbakht and AOA Dx CEO Oriana Papin-Zoghbi spoke with 360Dx about the urgent need for better ovarian cancer diagnostics, highlighting how vague symptoms delay care and the role of innovation and data in closing this critical diagnostic gap. #OvarianCancer

👏Full article: bit.ly/3ZMxqa3

The evolving role of HER2 in gynecologic oncology and clinical trial design: A gynecologic pathologist's perspective

Insights on IHC testing for clinical decision making - put together by our talented Gyn Onc Path team! Shout to Dr. Rebecca Wolsky.

@cucancercenter.bsky.social

www.sciencedirect.com/science/arti...

Join Computational Bioscience (CPBS) Program student Weishan Li for a talk on "Deriving Cell Type Specific Expression Profiles from HGSC using BuDDI"

Date 📅: Tomorrow (5/21/2025) 1PM MST
Location📍: RC1 North, Room 8108 & Zoom: ucdenver.zoom.us/j/9780564841...

#OvarianCancer #GynOnc #CUAnschutz